Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy

被引:0
|
作者
Daly, Mairead [1 ]
McDaid, Lisa [2 ]
Anandadas, Carmel [3 ]
Brocklehurst, Andrew [3 ]
Choudhury, Ananya [1 ,3 ]
McWilliam, Alan [1 ,4 ]
Radhakrishna, Ganesh [1 ,3 ]
Eccles, Cynthia L. [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester M13 9PL, England
[2] Christie NHS Fdn Trust, Dept Radiotherapy, Manchester M20 4BX, England
[3] Christie Hosp NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, England
[4] Christie Hosp NHS Fdn Trust, Dept Med Phys & Engn, Manchester M20 4BX, England
关键词
Motion management; MR-guided radiotherapy; SABR; SBRT; IGRT; INTEROBSERVER VARIABILITY; VOLUME DELINEATION; MRI; SEGMENTATION; CANCER;
D O I
10.1016/j.phro.2024.100650
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The impact of respiratory motion management strategies for abdominal radiotherapy, such as abdominal compression (AC) and breath hold (BH), on abdominal organ at risk (OAR) delineation on magnetic resonance imaging (MRI) is unknown. This feasibility study compared the inter- and intra- observer delineation variation on MRI acquired with AC, BH for three critical abdominal OAR. Materials and methods: T2-weighted (W) 3D MRI in free-breathing (FB) and with AC, and T1W 3D mDixon exhale BH were acquired. Four observers blinded to motion management strategy used, delineated stomach, liver, and duodenum on all MRI. One case per strategy was repeated over 6 weeks later to quantify intra-observer variation. Simultaneous truth and performance level estimation (STAPLE) contours for each OAR were generated, median and IQR mean distance to agreement (mDTA) and maximum Hausdorff distance (HD) between observer and STAPLE contours were calculated. Observers scored organ visibility on each MRI using a four-point Likert scale. Results: A total of 27 scans including repeats were delineated. Pooled mDTA for all OARs was 1.3 mm (0.5 mm) with AC, 1.4 mm (1.0 mm) with BH, and 1.3 mm (0.5 mm) in FB. Intra-observer mDTA was highest for all organs in FB with 10.8 mm for duodenum, 1.8 mm for liver, and 2.7 mm for stomach. The pooled mean perceptual quality score value was highest for AC across organs. Conclusions: No motion management strategy demonstrated superior similarity across OAR, emphasizing the need for personalised approaches based on individual clinical and patient factors.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Complex Abdominal Organ Motion Assessed From Magnetic Resonance Imaging
    Omari, E. A.
    Song, Y.
    Christian, J.
    Paulson, E. S.
    Erickson, B. A.
    Li, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E696 - E697
  • [42] Dosimetric evaluation of respiratory gating on a 0.35-T magnetic resonance-guided radiotherapy linac
    Charters, John A.
    Abdulkadir, Yasin
    O'Connell, Dylan
    Yang, Yingli
    Lamb, James M.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2022, 23 (09):
  • [43] A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies
    Mittauer, Kathryn
    Paliwal, Bhudatt
    Hill, Patrick
    Bayouth, John E.
    Geurts, Mark W.
    Baschnagel, Andrew M.
    Bradley, Kristin A.
    Harari, Paul M.
    Rosenberg, Stephen
    Brower, Jeffrey V.
    Wojcieszynski, Andrzej P.
    Hullett, Craig
    Bayliss, R. A.
    Labby, Zacariah E.
    Bassetti, Michael F.
    CUREUS, 2018, 10 (04):
  • [44] Magnetic resonance-guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system
    Boldrini, Luca
    Colloca, Giuseppe F.
    Villani, Emanuele
    Chiloiro, Giuditta
    Bellieni, Andrea
    Manfrida, Stefania
    Cellini, Francesco
    Gambacorta, Maria Antonietta
    Valentini, Vincenzo
    TUMORI JOURNAL, 2021, 107 (01): : 26 - 31
  • [45] First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany
    Klueter, Sebastian
    Katayama, Sonja
    Spindeldreier, C. Katharina
    Koerber, Stefan A.
    Major, Gerald
    Alber, Markus
    Akbaba, Sati
    Debus, Juergen
    Hoerner-Rieber, Juliane
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (08) : 691 - 698
  • [46] Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas
    Taran, F. A.
    Tempany, C. M. C.
    Regan, L.
    Inbar, Y.
    Revel, A.
    Stewart, E. A.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2009, 34 (05) : 572 - 578
  • [47] 1.5-Tesla Magnetic Resonance-Guided Adaptive Stereotactic Body Radiotherapy for Liver Malignancies
    Onal, C.
    Yavas, G.
    Yavas, C.
    Arslan, G.
    Efe, E.
    Haberal, M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1117 - S1117
  • [48] Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report
    Tyran, Marguerite
    Cao, Minsong
    Raldow, Ann C.
    Dang, Audrey
    Lamb, James
    Low, Daniel A.
    Steinberg, Michael L.
    Lee, Percy
    CUREUS, 2018, 10 (03):
  • [49] The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patients
    Nowee, Marlies E.
    van Pelt, Vivian W. J.
    Walraven, Iris
    Simoes, Rita
    Liskamp, Carmen P.
    Lambregts, Doenja M. J.
    Heijmink, Stijn
    Schaake, Eva
    van der Heide, Uulke A.
    Janssen, Tomas M.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2021, 19 : 85 - 89
  • [50] First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany
    Sebastian Klüter
    Sonja Katayama
    C. Katharina Spindeldreier
    Stefan A. Koerber
    Gerald Major
    Markus Alber
    Sati Akbaba
    Jürgen Debus
    Juliane Hörner-Rieber
    Strahlentherapie und Onkologie, 2020, 196 : 691 - 698